Treating nondementia illnesses in patients with dementia

Daniel J. Brauner, J. Cameron Muir, Greg Sachs

Research output: Contribution to journalArticle

115 Citations (Scopus)

Abstract

Physicians increasingly are called on to provide primary care for the growing population of people with Alzheimer-type dementia. However, little attention has been paid to the care of nondementia illnesses in this group of patients. To illustrate how presence of dementia can alter the risk-benefit ratio of treatment of a common medical problem, we present a case study in which a patient with dementia developed disastrous adverse effects to a drug commonly used to treat osteoporosis. This case and 2 composite vignettes illuminate how presence of dementia should influence the decision-making process for treatment of nondementia illnesses. We address issues such as decreased decision-making capacity, problems with reporting adverse effects, decreased cognition leading to problems with treatment adherence, and the role of screening and basic questions about acceptable burdens of treatments in patients with limited prognosis. We suggest ways to improve communication with patients with dementia in an effort to minimize complications and improve care, as well as policy changes to include patients with dementia in clinical trials.

Original languageEnglish (US)
Pages (from-to)3230-3235
Number of pages6
JournalJournal of the American Medical Association
Volume283
Issue number24
StatePublished - Jun 28 2000
Externally publishedYes

Fingerprint

Dementia
Decision Making
Therapeutics
Cognition
Osteoporosis
Primary Health Care
Alzheimer Disease
Odds Ratio
Communication
Clinical Trials
Physicians
Pharmaceutical Preparations
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Treating nondementia illnesses in patients with dementia. / Brauner, Daniel J.; Muir, J. Cameron; Sachs, Greg.

In: Journal of the American Medical Association, Vol. 283, No. 24, 28.06.2000, p. 3230-3235.

Research output: Contribution to journalArticle

Brauner, Daniel J. ; Muir, J. Cameron ; Sachs, Greg. / Treating nondementia illnesses in patients with dementia. In: Journal of the American Medical Association. 2000 ; Vol. 283, No. 24. pp. 3230-3235.
@article{74835d40af84406e86dc9316bd0253ef,
title = "Treating nondementia illnesses in patients with dementia",
abstract = "Physicians increasingly are called on to provide primary care for the growing population of people with Alzheimer-type dementia. However, little attention has been paid to the care of nondementia illnesses in this group of patients. To illustrate how presence of dementia can alter the risk-benefit ratio of treatment of a common medical problem, we present a case study in which a patient with dementia developed disastrous adverse effects to a drug commonly used to treat osteoporosis. This case and 2 composite vignettes illuminate how presence of dementia should influence the decision-making process for treatment of nondementia illnesses. We address issues such as decreased decision-making capacity, problems with reporting adverse effects, decreased cognition leading to problems with treatment adherence, and the role of screening and basic questions about acceptable burdens of treatments in patients with limited prognosis. We suggest ways to improve communication with patients with dementia in an effort to minimize complications and improve care, as well as policy changes to include patients with dementia in clinical trials.",
author = "Brauner, {Daniel J.} and Muir, {J. Cameron} and Greg Sachs",
year = "2000",
month = "6",
day = "28",
language = "English (US)",
volume = "283",
pages = "3230--3235",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "24",

}

TY - JOUR

T1 - Treating nondementia illnesses in patients with dementia

AU - Brauner, Daniel J.

AU - Muir, J. Cameron

AU - Sachs, Greg

PY - 2000/6/28

Y1 - 2000/6/28

N2 - Physicians increasingly are called on to provide primary care for the growing population of people with Alzheimer-type dementia. However, little attention has been paid to the care of nondementia illnesses in this group of patients. To illustrate how presence of dementia can alter the risk-benefit ratio of treatment of a common medical problem, we present a case study in which a patient with dementia developed disastrous adverse effects to a drug commonly used to treat osteoporosis. This case and 2 composite vignettes illuminate how presence of dementia should influence the decision-making process for treatment of nondementia illnesses. We address issues such as decreased decision-making capacity, problems with reporting adverse effects, decreased cognition leading to problems with treatment adherence, and the role of screening and basic questions about acceptable burdens of treatments in patients with limited prognosis. We suggest ways to improve communication with patients with dementia in an effort to minimize complications and improve care, as well as policy changes to include patients with dementia in clinical trials.

AB - Physicians increasingly are called on to provide primary care for the growing population of people with Alzheimer-type dementia. However, little attention has been paid to the care of nondementia illnesses in this group of patients. To illustrate how presence of dementia can alter the risk-benefit ratio of treatment of a common medical problem, we present a case study in which a patient with dementia developed disastrous adverse effects to a drug commonly used to treat osteoporosis. This case and 2 composite vignettes illuminate how presence of dementia should influence the decision-making process for treatment of nondementia illnesses. We address issues such as decreased decision-making capacity, problems with reporting adverse effects, decreased cognition leading to problems with treatment adherence, and the role of screening and basic questions about acceptable burdens of treatments in patients with limited prognosis. We suggest ways to improve communication with patients with dementia in an effort to minimize complications and improve care, as well as policy changes to include patients with dementia in clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=0034725349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034725349&partnerID=8YFLogxK

M3 - Article

VL - 283

SP - 3230

EP - 3235

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 24

ER -